American Journal of Cardiology
Volume 105, Issue 2 , Pages 198-204 , 15 January 2010

Tolerability of Red Yeast Rice (2,400 mg Twice Daily) Versus Pravastatin (20 mg Twice Daily) in Patients With Previous Statin Intolerance

  • Steven C. Halbert, MD

      Affiliations

    • Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • Jefferson-Myrna Brind Center for Integrative Medicine, Philadelphia, Pennsylvania
    • ,
  • Benjamin French, PhD

      Affiliations

    • Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • ,
  • Ram Y. Gordon, MD

      Affiliations

    • Division of Cardiology, Chestnut Hill Hospital, University of Pennsylvania Health System, Philadelphia, Pennsylvania
    • ,
  • John T. Farrar, MD

      Affiliations

    • Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • ,
  • Kathryn Schmitz, PhD

      Affiliations

    • Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • ,
  • Patti B. Morris, RD

      Affiliations

    • Division of Cardiology, Chestnut Hill Hospital, University of Pennsylvania Health System, Philadelphia, Pennsylvania
    • ,
  • Paul D. Thompson, MD

      Affiliations

    • Division of Cardiology, Hartford Hospital, Hartford, Connecticut
    • ,
  • Daniel J. Rader, MD

      Affiliations

    • Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • Institute for Translational Medicine and Therapeutics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    • ,
  • David J. Becker, MD

      Affiliations

    • Division of Cardiology, Chestnut Hill Hospital, University of Pennsylvania Health System, Philadelphia, Pennsylvania
    • Corresponding Author InformationCorresponding author: Tel: (215) 233-9700; fax: (215) 233-9710

Received 18 June 2009 ,Revised 25 August 2009 ,Accepted 25 August 2009.

References 

  1. Thompson PD, Clarkson P, Karas RH. Statin-associated myopathy. JAMA. 2003;289:1681–1690
  2. Li YG, Zhang F, Wang ZT, Hu ZB. Identification and chemical profiling of monacolins in red yeast rice using high-performance liquid chromatography with photodiode array detector and mass spectrometry. J Pharm Biomed Anal. 2004;35:1101–1112
  3. Ma J, Li Y, Ye Q, Li J, Hua Y, Ju D, et al. Constituents of red yeast rice, a traditional Chinese food and medicine. J Agric Food Chem. 2000;48:5220–5225
  4. In: Supplement Business Report 2009. Boulder, CO: Nutrition Business Journal; 2009;p. 44
  5. Becker DJ, Gordon RY, Morris PB, Yorko J, Gordon YJ, Li M, et al. Simvastatin vs therapeutic lifestyle changes and supplements: randomized primary prevention trial. Mayo Clin Proc. 2008;83:758–764
  6. Heber D, Yip I, Ashley JM, Elashoff DA, Elashoff RM, Go VL. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am J Clin Nutr. 1999;69:231–236
  7. Lu Z, Kou W, Du B, Wu Y, Zhao S, Brusco OA, et al. Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction. Am J Cardiol. 2008;101:1689–1693
  8. Becker DJ, Gordon J, Halbert SC, French B, Morris PB, Rader DJ. Red yeast rice versus placebo in dyslipidemic, statin-intolerant patients enrolled in a therapeutic lifestyle program: a randomized, controlled trial. Ann Intern Med. 2009;150:830–839
  9. Keller S, Bann CM, Dodd SL, Schein J, Mendoza TR, Cleeland CS. Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain. Clin J Pain. 2004;20:309–318
  10. Martin HJ, Yule V, Syddall HE, Dennison EM, Cooper C, Aihie SA. Is hand-held dynamometry useful for the measurement of quadriceps strength in older people? (A comparison with the gold standard Bodex dynamometry). Gerontology. 2006;52:154–159
  11. Thomson CA, Giuliano A, Rock CL, Ritenbaugh CK, Flatt SW, Faerber S, et al. Measuring dietary change in a diet intervention trial: comparing food frequency questionnaire and dietary recalls. Am J Epidemiol. 2003;157:754–762
  12. Paffenbarger RS, Hyde RT, Wing AL, Hsieh CC. Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med. 1986;314:605–613
  13. Dallal G. Randomization.com. www.randomization.comAccessed May 2, 2008
  14. Bruckert E, Hayem G, Dejager S, Yau C, Begaud B. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients—the PRIMO study. Cardiovasc Drugs Ther. 2005;19:403–414
  15. Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13–22
  16. Simon R. Patient subsets and variation in therapeutic efficacy. Br J Clin Pharmacol. 1982;14:473–482
  17. Hansen KE, Hildebrand JP, Ferguson EE, Stein JH. Outcomes in 45 patients with statin-associated myopathy. Arch Intern Med. 2005;165:2671–2676
  18. Backes JM, Moriarty PM, Ruisinger JF, Gibson CA. Effects of once weekly rosuvastatin among patients with a prior statin intolerance. Am J Cardiol. 2007;100:554–555
  19. Gadarla M, Kearns AK, Thompson PD. Efficacy of rosuvastatin (5 mg and 10 mg) twice a week in patients intolerant to daily statins. Am J Cardiol. 2008;101:1747–1748
  20. Backes JM, Venero CV, Gibson CA, Ruisinger JF, Howard PA, Thompson PD, et al. Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance. Ann Pharmacother. 2008;42:341–346
  21. Glueck CJ, Aregawi D, Agloria M, Khalil Q, Winiarska M, Munjal J, et al. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies. Clin Ther. 2006;28:933–942
  22. Stein EA, Ballantyne CM, Windler E, Simes PA, Sussekov A, Yigit Z, et al. Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins. Am J Cardiol. 2008;101:490–496
  23. Mackie BD, Satija S, Nell C, Miller J, Sperling LS. Monday, Wednesday and Friday dosing of rosuvastatin in patients previously intolerant to statin therapy. Am J Cardiol. 2007;99:291
  24. Jacobson TA. Statin safety: lessons from new drug applications for marketed statins. Am J Cardiol. 2006;97:44C–51C
  25. Li Z, Seeram NP, Lee R, Thames G, Minutti C, Wang HJ, et al. Plasma clearance of lovastatin versus Chinese red yeast rice in healthy volunteers. J Altern Complement Med. 2005;11:1031–1038
  26. Thompson PD, Clarkson PM, Rosenson RS. An assessment of statin safety by muscle experts. Am J Cardiol. 2006;97:69C–76C
  27. Franc S, Dejager S, Bruckert E, Chauvenet M, Giral P, Turpin G. A comprehensive description of muscle symptoms associated with lipid-lowering drugs. Cardiovasc Drugs Ther. 2003;17:459–465
  28. Heber D, Lembertas A, Lu QY, Bowerman S, Go VL. An analysis of nine proprietary Chinese red yeast rice dietary supplements: implications of variability in chemical profile and contents. J Altern Complement Med. 2001;7:133–139

 This study was supported by an unrestricted grant from the Commonwealth of Pennsylvania, and Chestnut Hill Health System, Philadelphia, Pennsylvania. Dr. Halbert was supported by grant T32AT000600 from the National Center for Complementary and Alternative Medicine, Bethesda, Maryland, and grant T32AG000253 from the National Institute on Aging, Bethesda, Maryland.

PII: S0002-9149(09)02325-X

doi: 10.1016/j.amjcard.2009.08.672

American Journal of Cardiology
Volume 105, Issue 2 , Pages 198-204 , 15 January 2010

Article Tools

* Image Usage & Resolution